X0508 4 2024-05-17 0000313143 HAEMONETICS CORP HAE 0001750812 Llorens Josep 125 SUMMER STREET BOSTON MA 02110 1 EVP, Global Manufacturing 1 Common Stock 2024-05-17 4 S 0 822 94.82 D 16350 D Common Stock 2024-05-17 4 F 0 320 95.73 D 16030 D Common Stock 2024-05-17 4 A 0 6267 A 22297 D Common Stock 2024-05-20 4 S 0 987 95.08 D 21310 D Transaction pursuant to an existing 10b5-1 trading plan dated August 28, 2023 (fully executed as of August 31, 2023). This number includes unvested restricted stock units ("RSUs") previously reported. Represents shares withheld for tax obligations in connection with the vesting of certain RSUs previously reported in Table I. The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. /s/ Thomas V. Powers, attorney-in-fact for Mr. Llorens 2024-05-21